Welcome to LookChem.com Sign In|Join Free
  • or
3'-(TRIFLUOROMETHYL)PROPIOPHENONE is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1533-03-5

Post Buying Request

1533-03-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1533-03-5 Usage

Chemical Properties

Colorless liquid

Check Digit Verification of cas no

The CAS Registry Mumber 1533-03-5 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,5,3 and 3 respectively; the second part has 2 digits, 0 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1533-03:
(6*1)+(5*5)+(4*3)+(3*3)+(2*0)+(1*3)=55
55 % 10 = 5
So 1533-03-5 is a valid CAS Registry Number.
InChI:InChI=1/C9H12ClFSi/c1-12(2,3)9-5-4-7(10)6-8(9)11/h4-6H,1-3H3

1533-03-5 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (B20147)  3'-(Trifluoromethyl)propiophenone, 97%   

  • 1533-03-5

  • 1g

  • 200.0CNY

  • Detail
  • Alfa Aesar

  • (B20147)  3'-(Trifluoromethyl)propiophenone, 97%   

  • 1533-03-5

  • 5g

  • 803.0CNY

  • Detail
  • Alfa Aesar

  • (B20147)  3'-(Trifluoromethyl)propiophenone, 97%   

  • 1533-03-5

  • 25g

  • 3396.0CNY

  • Detail

1533-03-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 10, 2017

Revision Date: Aug 10, 2017

1.Identification

1.1 GHS Product identifier

Product name 3′-(Trifluoromethyl)propiophenone

1.2 Other means of identification

Product number -
Other names 3'-(TrifluoroMethyl)propiophenone

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1533-03-5 SDS

1533-03-5Relevant academic research and scientific papers

Stereoselective amination of racemic sec-alcohols through sequential application of laccases and transaminases

Martínez-Montero, Lía,Gotor, Vicente,Gotor-Fernández, Vicente,Lavandera, Iván

supporting information, p. 474 - 480 (2017/06/23)

A one-pot/two-step bienzymatic asymmetric amination of secondary alcohols is disclosed. The approach is based on a sequential strategy involving the use of a laccase/TEMPO catalytic system for the oxidation of alcohols into ketone intermediates, and their following transformation into optically enriched amines by using transaminases. Individual optimizations of the oxidation and biotransamination reactions have been carried out, studying later their applicability in a concurrent process. Therefore, 17 racemic (hetero) aromatic sec-alcohols with different substitutions in the aromatic ring have been converted into enantioenriched amines with good to excellent selectivities (90-99% ee) and conversion values (67-99%). The scalability of the process was also demonstrated when two different amine donors were used in the transamination step, such as isopropylamine and cis-2-buten-1,4-diamine. Satisfyingly, both sacrificial amine donors can shift the equilibrium toward the amine formation, leading to the corresponding isolated enantioenriched amines with good to excellent results.

CERAMIDE GALACTOSYLTRANSFERASE INHIBITORS FOR THE TREATMENT OF DISEASE

-

Paragraph 000505; 000506; 000547; 000548, (2018/01/17)

Described herein are compounds, methods of making such compounds, pharmaceutical compositions and medicaments containing such compounds, and methods of using such compounds to treat or prevent diseases or disorders associated with the enzyme ceramide galactosyltransferase (CGT), such as, for example, lysosomal storage diseases. Examples of lysosomal storage diseases include, for example, Krabbe disease and Metachromatic Leukodystrophy.

A chemoselective α-aminoxylation of aryl ketones: a cross dehydrogenative coupling reaction catalysed by Bu4NI

Siddaraju, Yogesh,Prabhu, Kandikere Ramaiah

supporting information, p. 11651 - 11656 (2015/12/08)

Tetrabutyl ammonium iodide (TBAI) catalyzed α-aminoxylation of ketones using aq. TBHP as an oxidant has been accomplished. We have shown that the CDC (cross dehydrogenative coupling) reactions of ketones with N-hydroxyimidates such as N-hydroxysuccinimide (NHSI), N-hydroxyphthalimide (NHPI), N-hydroxybenzotriazole (HOBt) and 1-hydroxy-7-azabenzotriazole (HOAt) lead to the corresponding oxygenated products in good to moderate yields. The application of this method has been demonstrated by transforming a few coupled products into synthetically useful intermediates and products.

Rhodium-catalyzed ortho acylation of aromatic carboxylic acids

Mamone, Patrizia,Danoun, Gregory,Goossen, Lukas J.

supporting information, p. 6704 - 6708 (2013/07/26)

New directions: The carboxylic acid functional group directs the ortho acylation of benzoic acids with carboxylic anhydrides in the presence of a rhodium catalyst (see scheme; cod=cyclo-1,5-octadiene). The acylation at the ortho position is complementary to the meta selectivity of Friedel-Crafts reactions. The resulting products can undergo protodecarboxylation to deliver an aryl ketone. Copyright

N, N′-dioxide-Cu(OTf)2 complex catalyzed highly enantioselective amination reaction of N-acetyl enamide

Chang, Lu,Kuang, Yulong,Qin, Bo,Zhou, Xin,Liu, Xiaohua,Lin, Lili,Feng, Xiaoming

supporting information; scheme or table, p. 2214 - 2217 (2010/08/06)

The N,N′-dioxide-Cu(OTf)2 complexes were applied in the asymmetric amination reaction of N-acetyl enamides with dialkyl azodicarboxylate, giving the corresponding products in good yields with high enantioselectivities (up to 91% ee). Precursors of vicinal diamine were readily obtained with excellent diastereoselectivities (>95:5) by NaBH4 reduction.

Process for the preparation of phenyl alkyl ketones and benzaldehydes

-

, (2008/06/13)

There is provided a process for the preparation of compounds of formula I wherein: X is H or F, Y is CF3or F and R1is hydrogen or C1-C2alkyl; in which process (1) a compound of formula II, wherein X and Y are as defined for formula I, is reacted with an organic or inorganic nitrite or nitrous acid; (2) the resulting diazonium compound of formula III is reacted with an aldoxime of formula V R1—CH═NOH ??(V) wherein R1is as defined for formula I, in presence of CuSO4; and (3) the resulting oxime of formula IV is hydrolyzed with aqueous acid to the compound of formula I.

Synthesis and evaluation of the anticonvulsant activity of a series of 2-amino-1-phenyl-1-propranols derived from the metabolites of the antidepressant bupropion

Musso, David L.,Mehta, Nariman B.,Soroko, Francis E.

, p. 1 - 6 (2007/10/03)

A series of 2-amino-1-phenyl-1-propanols that are structurally related to known metabolites of bupropion, 1 (Wellbutrin) were synthesized and evaluated as potential anticonvulsants. The (R*,R*)-2-tert-butylamino-1-(3-trifluoromethylphenyl) propanol 20 had an ED50 of 16.5 ± 2.8 mg/kg ip in mice in the maximal electroshock screen and was chosen for further evaluation.

Synthesis and activity of 2-methyl-3-aminopropiophenones as centrally acting muscle relaxants

Shiozawa,Narita,Izumi,Kurashige,Sakitama,Ishikawa

, p. 85 - 94 (2007/10/02)

Some novel 2-methyl-3-aminopropiophenones were synthesized and their centrally acting muscle relaxant activities were,evaluated for an inhibitory effect on the flexor reflex in rats. The structure-activity relationships are discussed. In this series 2-methyl-3-pyrrolidino-1-(4-trifluoromethylphenyl)-propan-1-one (28) showed significant centrally acting muscle relaxant activity. In addition, the activities of each enantiomer (28-(S) and (R)) were studied along with their acute toxicities. Compound 28-(R) was found to exhibit more potent activity and weaker acute toxicity than 28-(S). Accordingly, compound 28-(R) (NK433) is under development as a novel centrally acting muscle relaxant.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1533-03-5